RESEARCH
-
Contributing to the advancement of scientific knowledge
PREAMBLE We have already come to the end of this important series of articles about the national board and operational committees on which our volunteers...
-
Bridging the gap between generations and perspectives within our community
As a youth delegate representing Canada at the WFH 2024 World Congress, I found myself among experienced professionals, leaders of national hemophilia chapters, health care...
-
Research projects funded in 2024
It is safe to say that research provides better quality of life and will lead, one day, inevitably to cures. This is why the Canadian...
-
Update on coagulation products – current and in the pipeline
To access charts informing you of products in the PIPELINE, please CLICK HERE. To access charts informing you of CURRENT coagulation products, please CLICK HERE.
-
Opportunity to take part in a hemophilia B gene therapy trial
Hamilton, January 22, 2024 – McMaster University, in collaboration with CSL Behring, has announced a new gene therapy trial for etranacogene dezaparvovec (Hemgenix) in hemophilia...